PlainRecalls
FDA Drug Moderate Class II Terminated

NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA

Reported: July 21, 2021 Initiated: July 2, 2021 #D-0652-2021

Product Description

NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA

Reason for Recall

Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.

Details

Recalling Firm
The Harvard Drug Group
Units Affected
504 Cartons of 50 count each; 372 Cartons of 100 count each
Distribution
Distributed in OH and NJ
Location
Livonia, MI

Frequently Asked Questions

What product was recalled?
NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA. Recalled by The Harvard Drug Group. Units affected: 504 Cartons of 50 count each; 372 Cartons of 100 count each.
Why was this product recalled?
Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 21, 2021. Severity: Moderate. Recall number: D-0652-2021.